Tim Knotnerus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim knotnerus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Knotnerus Today - Breaking & Trending Today

Agomab Therapeutics NV: Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis

Agomab Therapeutics NV: Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Tim Knotnerus , Gretchen Schweitzer , Stefan Klotter , Trophic Communications , Single Ascending Dose , Multiple Ascending Dose , Chief Development Officer , Idiopathic Pulmonary Fibrosis , Fibrostenosing Crohn , Idiopathic Pulmonary , Transforming Growth Factor , Hepatocyte Growth Factor , Agomab Therapeutics , Stephanie May , Lassen Sie ,

Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis

GHENT, Belgium, December 14, 2023 Agomab Therapeutics NV (‘Agomab’) today announced that it has dosed the first subject in a first-in-human Phase 1 clinical study of AGMB-447, an inhaled lung-restricted small molecule inhibitor of ALK5 (TGFβRI or ALK5). The study is evaluating AGMB-447 in healthy subjects and in patients with idiopathic pulmonary fibrosis (IPF). ....

Gretchen Schweitzer , Tim Knotnerus , Trophic Communications , Agomab Therapeutics , Single Ascending Dose , Multiple Ascending Dose , Chief Development Officer , Idiopathic Pulmonary Fibrosis , Fibrostenosing Crohn , Idiopathic Pulmonary , Transforming Growth Factor , Hepatocyte Growth Factor , Stephanie May , Lung Transplant , Lung Diseases , Business Wire ,

Agomab Therapeutics: Agomab Appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

Agomab Therapeutics: Agomab Appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Paolo Michieli , Tim Knotnerus , Torsten Dreier , Gretchen Schweitzer , Stefan Klotter , Angelika Jahreis , Osteoarthritis Drug Development Workshops , University Of Freiburg , Pompeu Fabra University , Development Officer , Regulatory Affairs , Development Unit Head Of Immunology At Novartis , Trophic Communications , Scripps Research Institute In La Jolla , Senior Vice President , Development Unit Head , Origo Biopharma , Chief Development , Chief Scientific Officer , Chief Development Officer , Scientific Advisory Board , Chief Executive Officer , Idiopathic Pulmonary Fibrosis , Agomab Therapeutics , Scripps Research Institute , Osteoarthritis Drug Development ,

Agomab Appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

Agomab Appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tim Knotnerus , Paolo Michieli , Angelika Jahreis , Gretchen Schweitzer , Torsten Dreier , Development Officer , University Of Freiburg , Pompeu Fabra University , Regulatory Affairs , Development Unit Head Of Immunology At Novartis , Trophic Communications , Scripps Research Institute In La Jolla , Osteoarthritis Drug Development Workshops , Senior Vice President , Development Unit Head , Origo Biopharma , Chief Development , Chief Scientific Officer , Chief Development Officer , Scientific Advisory Board , Chief Executive Officer , Idiopathic Pulmonary Fibrosis , Agomab Therapeutics , Scripps Research Institute , Osteoarthritis Drug Development , Hebron Hospital ,

Agomab Therapeutics NV: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

Agomab Therapeutics NV: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Colleen Cuffaro , Tim Knotnerus , Felice Verduyn Van Weegen , Iyona Rajkomar , Fidelity Management Research Company , Trophic Communications , Life Sciences , Dawn Biopharma , Fibrostenosing Crohn , Idiopathic Pulmonary Fibrosis , Felice Verduyn , Chief Executive Officer , Agomab Therapeutics , Stephanie May , Aktien Sie ,